Role of allergies in diagnostics and treatment of HIV-infection
https://doi.org/10.34680/2076-8052.2021.1(122).67-70
Abstract
The paper gives a brief literature review of the development of allergic reactions associated with HIV infection. Main statistic data of HIV and allergic diseases in the Russian Federation was reviewed. Information on the development of allergic diseases in HIVinfected patients based on clinical and laboratory data is presented. Special attention in the study of allergies in HIV-infected patients is paid to drug hypersensitivity since allergic reactions to certain drugs may complicate the selection of antiretroviral therapy and treatment of comorbidity. Drug hypersensitivity is considered for each class of drugs used for antiretroviral therapy in HIV-infected patients. Certain examples of antiretroviral drugs that often develop allergic reactions are given.
About the Authors
S. A. Nora
Novgorod State University
Russian Federation
Russian Federation
Veliky Novgorod
G. S. Arkhipov
Novgorod State University
Russian Federation
Russian Federation
Veliky Novgorod
i G. Kropachev
Novgorod State University
Russian Federation
Russian Federation
Veliky Novgorod
E. I. Arkhipova
Novgorod State University
Russian Federation
Russian Federation
Veliky Novgorod
References
1. Pirogova I.A. Rasprostranennost' VICh-infektsii v Rossii [HIV prevalence in Russia]. Vestnik SMUS74, no.4 (19), pp. 45-49.
2. Zdravookhranenie v Rossii: Stat. sb. [Healthcare in Russia: Statistical digest] ROSSTAT. Moscow, 2017.
3. VICh-infektsiya. Informatsionnyy byulleten' № 44. Federal'nyy nauchno-metodicheskiy Tsentr po profilaktike i bor'be so SPIDom (2019) [HIV infection. Information Bulletin No. 44. Federal Scientific and Methodological Center for the Prevention and Control of AIDS (2019)].
4. Mokrousova M.A., Mats A.N. Infektsiya i allergiya: dve storony odnoy medali [Infection and allergy: two sides of the same coin]. Astma i allergiya, 2015, no. 4, pp. 9-12.
5. Freydin M.V., Puzyrev V.P. Genomnye osnovy podverzhennosti atopicheskim zabole-vaniyam [Genomic bases of susceptibility to atopic diseases]. Molekulyarnaya meditsina, 2007, no. 3, pp. 26-35.
6. Hershey G.K.K., Friedrich M.F., Esswein L.A. et al. The association of atopy with a gain of function mutation in the αsubunit of the interleukin 4 receptor. New Eng. J. Med., 1997, vol. 337, p. 1720-1725.
7. Mitsuyasu H., Yanagihara Y., Mao X.Q. et al. Dominant effect of Ile50Val variant of the hu-man IL-4 receptor αchain in IgE synthesis. J. Immunol., 1999, vol. 162, pp. 12271231.
8. Simonov R.O. et al. Ostrye allergozy u VIChinfitsirovannykh patsientov na fone glistnoy invazii [Acute allergies in HIV-infected patients against the background of helminthic infection]. Diagnostika i lechenie glaznykh proyavleniy infektsionnykh i sistemnykh zabolevaniy, 2018, pp. 98-105.
9. Akhmedzhanova Z.I. Chastota allergicheskikh zabolevaniy u VICh-infitsirovannykh / Z.I. Akhmedzhanova [Frequency of allergic diseases in HIV-infected]. Meditsinskaya immunologiya, 2009, vol. 1, pp. 4-5.
10. Rhode D., Vanker A. Human immunodeficiency virus and allergic disease. Current Allergy & Clinical Immunology, 2009, vol. 22, no. 4, pp. 168-172.
11. Davis C.M., Shearer W.T. Diagnosis and management of HIV drug hypersensitivity. J. Allergy Clin. Immunol., 2008, vol. 121(4), pp. 826-832.e5. doi: 10.1016/j.jaci.2007.10.021.
12. Borrás-Blasco J., Navarro-Ruiz A., Borrás C. et al. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. J Antimicrob. Chemother., 2008, vol. 62(5), pp. 879-88. doi: 10.1093/jac/dkn292.
13. Symonds W., Cutrell A., Edwards M. et al. Risk factor analysis of hypersensitivity reactions to abacavir. Clin Ther., 2002, vol. 24(4), pp. 565-73. doi: 10.1016/s0149-2918(02)85132-3.
14. Temesgen Z., Beri G. HIV and drug allergy. Immunol. Allergy Clin. North. Am., 2004, vol. 24(3), pp. 521-31, viii. doi: 10.1016/j.iac.2004.03.006
15. Montessori V., Press N., Harris M. et al. Adverse effects of antiretroviral therapy for HIV infection. CMAJ, 2004, vol. 170(2), pp. 229-38.
16. Mehta U., Maartens G. Is it safe to switch between efavirenz and nevirapine in the event of toxicity? Lancet Infect Dis., 2007, vol. 11, pp. 733-8. doi: 10.1016/S14733099(07)70262-1.
17. Yunihastuti E., Widhani A., Karjadi T.H. Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management. Asia Pac. Allergy, 2014, v.4(1), p.54-67. doi: 10.5415/apallergy.2014.4.1.54.
18. Shahar E., Moar C., Pollack S. Successful desensitization of enfuvirtide-induced skin hyper-sensitivity reaction. AIDS, 2005, vol.19(4), pp.451-2. doi: 10.1097/ 01.aids.0000161779.23191.e5.
19. Walmsley S.L., Antela A., Clumeck N. et al. Dolutegravir plus Abacavir-Lamivudine for the treatment of HIV-1 infection. N. Engl. J. Med., 2013, vol. 369(19), pp. 1807-18. doi: 10.1056/NEJMoa1215541.
20. Grant A.D., Mngadi K.T., van Halsema C.L. Adverse events with isoniazid preventive therapy: experience from a large trial. AIDS, vol. 24, suppl. 5, pp. S29-S36. doi: 10.1097/01.aids.0000391019.10661.66.
21. Craig T.J., Peralta F., Boggavarapu J. Desensitization for fluconazole hypersensitivity. J Allergy Clin Immunol. 1996, vol. 98(4), pp. 845-6. doi: 10.1016/s00916749(96)70136-7.
Review
For citations:
Nora S.A., Arkhipov G.S., Kropachev i.G., Arkhipova E.I. Role of allergies in diagnostics and treatment of HIV-infection. Title in english. 2021;(1(122)):67-70. (In Russ.) https://doi.org/10.34680/2076-8052.2021.1(122).67-70
Views:
41
Email this article 